Portola Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch PTLA and buy or sell other stocks, options, and ETFs commission-free!

About PTLA

Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic surgery; for stroke prevention in patients with atrial fibrillation; and for secondary prevention of myocardial infarction and stroke. 

CEO
J. Scott Garland, MBA
CEOJ. Scott Garland, MBA
Employees
Employees
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2003
Founded2003
Employees
Employees

PTLA Key Statistics

Market cap
1.42B
Market cap1.42B
Price-Earnings ratio
-4.78
Price-Earnings ratio-4.78
Dividend yield
Dividend yield
Average volume
2.32M
Average volume2.32M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$31.73
52 Week high$31.73
52 Week low
$5.31
52 Week low$5.31
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.